Active, Not Recruiting
Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases
NCT03457948
- Conditions
- Metastatic Malignant Neoplasm in the Liver, Neoplasms, Neoplasms by Histologic Type, +5 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States